Evidence map›Paper›PMID 25644686›Full record

ReviewRedox biology2015

Oxidative stress in severe acute illness.

David Bar-Or, Raphael Bar-Or, Leonard T Rael, Edward N Brody

Open access · goldAbstract readReview
In one paragraph

Review in Redox biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Modulating Activity Evaluation of Gut Microbiota with Versatile Toluquinol.International journal of molecular sciences · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

David Bar-OrSwedish Medical Center, Englewood, CO, USA; St. Anthony Hospital, Lakewood, CO, USA; The Medical Center of Plano, Plano, TX, USA. Electronic address: dbaror@ampiopharma.com.
Raphael Bar-OrSwedish Medical Center, Englewood, CO, USA; St. Anthony Hospital, Lakewood, CO, USA; The Medical Center of Plano, Plano, TX, USA. Electronic address: rbaror@ampiopharma.com.
Leonard T RaelSwedish Medical Center, Englewood, CO, USA; St. Anthony Hospital, Lakewood, CO, USA; The Medical Center of Plano, Plano, TX, USA. Electronic address: lrael@ampiopharma.com.
Edward N BrodySomaLogic, Inc., Boulder, CO, USA. Electronic address: ebrody@somalogic.com.
St. Anthony Hospital · USSomaLogic (United States) · USSwedish Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The overall redox potential of a cell is primarily determined by oxidizable/reducible chemical pairs, including glutathione-glutathione disulfide, reduced thioredoxin-oxidized thioredoxin, and NAD(+)-NADH (and NADP-NADPH). Current methods for evaluating oxidative stress rely on detecting levels of individual byproducts of oxidative damage or by determining the total levels or activity of individual antioxidant enzymes. Oxidation-reduction potential (ORP), on the other hand, is an integrated, comprehensive measure of the balance between total (known and unknown) pro-oxidant and antioxidant components in a biological system. Much emphasis has been placed on the role of oxidative stress in chronic diseases, such as Alzheimer's disease and atherosclerosis. The role of oxidative stress in acute diseases often seen in the emergency room and intensive care unit is considerable. New tools for the rapid, inexpensive measurement of both redox potential and total redox capacity should aid in introducing a new body of literature on the role of oxidative stress in acute illness and how to screen and monitor for potentially beneficial pharmacologic agents.

Indexed as

Acute DiseaseAntioxidantsBrain InjuriesGlutathioneGlutathione PeroxidaseGlutathione ReductaseHumansMultiple TraumaMyocardial InfarctionNADOxidative StressReactive Oxygen SpeciesSepsisStrokeSuperoxide DismutaseThioredoxinsAntioxidantsGlutathioneGlutathione PeroxidaseGlutathione ReductaseNADReactive Oxygen SpeciesSuperoxide DismutaseThioredoxins4-HydroxynonenalHypoxia-inducible factor 1MalondialdehydeOxidation reduction potentialSuperoxide dismutaseTraumatic brain injury

Identifiers

PMID25644686
PMCPMC4326179
OpenAlexW1999890415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.